多重耐药菌的当前观点。流行病学与控制。
Current perspectives on multidrug-resistant bacteria. Epidemiology and control.
作者信息
Segal-Maurer S, Urban C, Rahal J J
机构信息
Cornell University Medical College, New York, USA.
出版信息
Infect Dis Clin North Am. 1996 Dec;10(4):939-57. doi: 10.1016/s0891-5520(05)70334-2.
PMID:8958176
Abstract
Antimicrobial resistance in bacteria has diminished the availability of effective antimicrobial agents. Knowledge of epidemiology, mechanisms of resistance, and new diagnostic modalities can help to identify and treat patients at risk for infection by these organisms. Limited or nonexistent effective microbial therapy underscores the importance of effective preventive and containment measures.
摘要
细菌中的抗微生物药物耐药性降低了有效抗微生物药物的可及性。了解流行病学、耐药机制和新的诊断方法有助于识别和治疗有感染这些微生物风险的患者。有效微生物治疗有限或不存在凸显了有效预防和控制措施的重要性。
相似文献
1
Current perspectives on multidrug-resistant bacteria. Epidemiology and control.多重耐药菌的当前观点。流行病学与控制。
Infect Dis Clin North Am. 1996 Dec;10(4):939-57. doi: 10.1016/s0891-5520(05)70334-2.
2
In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.利奈唑胺对耐万古霉素肠球菌、耐甲氧西林金黄色葡萄球菌和耐青霉素肺炎链球菌的体外活性。
Diagn Microbiol Infect Dis. 1999 Jun;34(2):119-22. doi: 10.1016/s0732-8893(99)00016-4.
3
Antimicrobial resistance in India and the United States.印度和美国的抗菌药物耐药性
Clin Infect Dis. 1996 Dec;23(6):1315-6. doi: 10.1093/clinids/23.6.1315.
4
Antibiotic resistance in bacteria. A current and future problem.细菌中的抗生素耐药性：当前及未来的问题
Adv Exp Med Biol. 1999;455:387-96.
5
Resistance patterns among nosocomial pathogens: trends over the past few years.医院病原体的耐药模式：过去几年的趋势
Chest. 2001 Feb;119(2 Suppl):397S-404S. doi: 10.1378/chest.119.2_suppl.397s.
6
Current challenges in antibiotic resistance.抗生素耐药性的当前挑战。
Adolesc Med. 2000 Jun;11(2):427-38.
7
Infections due to drug-resistant pneumococci, enterococci, and Mycobacterium tuberculosis.由耐药肺炎球菌、肠球菌和结核分枝杆菌引起的感染。
Pediatr Ann. 1996 Sep;25(9):502-10. doi: 10.3928/0090-4481-19960901-08.
8
In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.GAR-936对耐万古霉素肠球菌、耐甲氧西林金黄色葡萄球菌和耐青霉素肺炎链球菌的体外活性。
Diagn Microbiol Infect Dis. 2000 Nov;38(3):177-9. doi: 10.1016/s0732-8893(00)00193-0.
9
Antimicrobial-resistant pathogens in the 1990s.20世纪90年代的抗菌药物耐药性病原体。
Annu Rev Med. 1996;47:169-79. doi: 10.1146/annurev.med.47.1.169.
10
Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities.耐甲氧西林金黄色葡萄球菌和耐万古霉素肠球菌：治疗现状与前景
Lancet. 1997 Jun 28;349(9069):1901-6. doi: 10.1016/s0140-6736(96)11192-2.
Zotero 插件